PM
CVAC

Parametrica Management’s CureVac CVAC Stock Holding History

Parametrica Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,513
Closed -$184K – 95
2022
Q2 		$184K Buy
+13,513
New +$224K 0.2% 133
2021
Q2 		– Sell
-44,695
Closed -$3.97M – 119
2021
Q1 		$3.97M Buy
44,695
+6,365
+17% +$617K 1.91% 13
2020
Q4 		$3.11M Buy
+38,330
New +$2.93M 1.92% 13

Other funds holding CVAC

GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parametrica Management's CVAC Position: Q3 2022 in Review

Parametrica Management sold out of CureVac (CVAC) in Q3 2022, closing a stake of 13,513 shares — an estimated $184K sold.

Parametrica Management first reported a position in CVAC in Q4 2020 and held it in 3 quarters. The position peaked at $3.97M in Q1 2021. 83 funds tracked by Wall St. Rank hold CVAC as of Q3 2022.

  • Parametrica Management reported no remaining CureVac position as of Q3 2022 after selling out during the quarter.
  • Parametrica Management sold 13,513 CureVac shares in Q3 2022, an estimated $184K.
  • Parametrica Management first reported a position in CureVac in Q4 2020 and held it in 3 quarters.
  • Parametrica Management's CureVac position peaked at $3.97M in Q1 2021.
  • 83 funds tracked by Wall St. Rank held CureVac as of Q3 2022.

Based on Parametrica Management's 13F filing for Q3 2022, filed 3 Nov 2022.